Authors: Bassan, R Rohatiner, AZ Di Bona, E Lerede, T Carter, M Rambaldi, A Pogliani, E Rossi, G Fabris, P Morandi, S Lambertenghi-Deliliers, G Lister, TA Barbui, T

Citation: R. Bassan et al., Prognostic factors in Philadelphia plus BCR-ABL plus acute lymphoblastic leukemia, HEMAT BLOOD, 40, 2001, pp. 426-431

Authors: Jenner, MJ Micallef, INM Rohatiner, AZ Kelsey, SM Newland, AC Cavenagh, JD

Citation: Mj. Jenner et al., Successful therapy of transplant-associated veno-occlusive disease with a combination of tissue plasminogen activator and defibrotide, MED ONCOL, 17(4), 2000, pp. 333-336

Authors: Vose, JM Wahl, RL Saleh, M Rohatiner, AZ Knox, SJ Radford, JA Zelenetz, AD Tidmarsh, GF Stagg, RJ Kaminski, MS

Citation: Jm. Vose et al., Multicenter phase II study of iodine-131 tositumomab for chemotherapy-relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin's lymphomas, J CL ONCOL, 18(6), 2000, pp. 1316-1323

Authors: Last, KW Goff, LK Summers, KE Neat, M Jenner, M Crawley, C Rohatiner, AZ Fitzgibbon, J Lister, TA

Citation: Kw. Last et al., Familial follicular lymphoma: A case report with molecular analysis, BR J HAEM, 110(3), 2000, pp. 744-745

Authors: Milligan, DW de Elvira, MCR Kolb, HJ Goldstome, AH Meloni, GA Rohatiner, AZ Colombat, P Schmitz, N

Citation: Dw. Milligan et al., Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT, BR J HAEM, 106(4), 1999, pp. 1020-1026